These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7776264)

  • 1. Ultrastructural finding of vascular degeneration in fibrodysplasia ossificans progressiva (FOP).
    el-Labban NG; Hopper C; Barber P
    J Oral Pathol Med; 1995 Mar; 24(3):125-9. PubMed ID: 7776264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural finding of vascular degeneration in myositis ossificans circumscripta (fibrodysplasia ossificans).
    el-Labban NG; Hopper C; Barber P
    J Oral Pathol Med; 1993 Oct; 22(9):428-31. PubMed ID: 8301610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degenerative changes in masseter and temporalis muscles in limited mouth opening and TMJ ankylosis.
    el-Labban NG; Harris M; Hopper C; Barber P
    J Oral Pathol Med; 1990 Oct; 19(9):423-5. PubMed ID: 2269937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TGFβ signaling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease.
    Micha D; Voermans E; Eekhoff MEW; van Essen HW; Zandieh-Doulabi B; Netelenbos C; Rustemeyer T; Sistermans EA; Pals G; Bravenboer N
    Bone; 2016 Mar; 84():169-180. PubMed ID: 26769004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrodysplasia ossificans progressiva and osteoimmunology].
    Katagiri T
    Clin Calcium; 2016 May; 26(5):691-8. PubMed ID: 27117614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amianthoid fibres in muscle tissue associated with temporomandibular joint ankylosis.
    el-Labban NG; Harris M; Hopper C; Barber P
    Ultrastruct Pathol; 1986; 10(6):571-6. PubMed ID: 3824558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrodysplasia ossificans circumscripta of the masseter muscle.
    Geist JR; Bhatti P; Plezia RA; Wesley RK
    Dentomaxillofac Radiol; 1998 May; 27(3):182-5. PubMed ID: 9693532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Door Opens for Fibrodysplasia Ossificans Progressiva.
    Katagiri T
    Trends Biochem Sci; 2016 Feb; 41(2):119-121. PubMed ID: 26654278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis ossificans in psoas muscle after lumbar spine fracture.
    Kim SW; Choi JH
    Spine (Phila Pa 1976); 2009 May; 34(10):E367-70. PubMed ID: 19404167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle imaging in fibrodysplasia ossificans progressiva: The neurologist's perspective.
    Tasca G; D'Amico A; Verardo M; Villani A; Siani P; De Brasi D; Bertini E; Boldrini R
    Neuromuscul Disord; 2015 Aug; 25(8):672-3. PubMed ID: 26077615
    [No Abstract]   [Full Text] [Related]  

  • 12. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
    van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
    J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic basis for skeletal disease. Establishment of novel treatments for fibrodysplasia ossificans progressiva (FOP)].
    Katagiri T
    Clin Calcium; 2010 Aug; 20(8):1204-11. PubMed ID: 20675931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traumatic myositis ossificans in the masseter muscle.
    Arima R; Shiba R; Hayashi T
    J Oral Maxillofac Surg; 1984 Aug; 42(8):521-6. PubMed ID: 6588169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrodysplasia ossificans progressiva.
    Tonholo-Silva ER; Adachi EA; Tafner MS; Yoshinaga L
    Arq Neuropsiquiatr; 1994 Mar; 52(1):100-2. PubMed ID: 8002796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrodysplasia ossificans progressiva.
    Newton MC; Allen PW; Ryan DC
    Br J Anaesth; 1990 Feb; 64(2):246-50. PubMed ID: 2317429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.
    Cai J; Orlova VV; Cai X; Eekhoff EMW; Zhang K; Pei D; Pan G; Mummery CL; Ten Dijke P
    Stem Cell Reports; 2015 Dec; 5(6):963-970. PubMed ID: 26626181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis between fibrodysplasia ossificans progressiva and childhood dermatomyositis with calcinosis.
    Wu T; Chen SS
    J Formos Med Assoc; 1993 Jun; 92(6):569-76. PubMed ID: 8106047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS; Smith RM
    J Bone Miner Res; 1997 May; 12(5):855. PubMed ID: 9144353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.